Plasminogen activator inhibitor‐1 is independently associated with non‐alcoholic fatty liver disease whereas leptin and adiponectin vary between genders

Abstract

PAI-1 is independently associated with NAFLD after adjusting for other factors, including leptin and adiponectin. Male and female NAFLD patients show distinct patterns of leptin and adiponectin alterations; special attention is required when evaluating these alterations in female NAFLD patients < 45 years.